PG

Phil Grayeski

Partner @ KdT Ventures

Raleigh-Durham-Chapel Hill Area

Investor
VC

Invests in

Stages:

Series A
Seed

  • Min Investment:

    $700,000.00

  • Max Investment:

    $1,000,000.00

  • Target Investment:

    $850,000.00

Skills

Research
Cell Culture

Education

Lists including Phil

AT
AS
AT
AH

All Series A Investors

14752 people

AM
AT
AS
AR

All Seed Investors

19695 people

Work Experience

KV
KdT Ventures

2018

  • Partner

    2021

    Board Observer: - Radar Therapeutics - Tacit Therapeutics - Circularis (acq. by Gingko Q4 2022) - Transcera

  • Principal

    2019 - 2021

  • Venture Associate

    2018 - 2019

Z
ZymoChem

2023

  • Board Member

    2023

CB
Cirsium Biosciences

2022

  • Board Member

    2022

PT
Perceptive Technologies (formerly Cyberdontics)

2022

  • Board Member

    2022

A
Andes

2020

  • Board Member

    2020

TB
Torque Bio

2018

  • Co-Founder

    2018

TI
Transcera Inc.

2021 - 2023

  • Board Member

    2021 - 2023

DI
Dimension Inx

2021 - 2023

  • Board Member

    2021 - 2023

SI
StrideBio, Inc

2015 - 2019

  • Strategy Advisor and Business Analyst

    2015 - 2019

    Acq. by Gingko Bioworks - May 2023

R
Ribometrix

2016 - 2017

  • Strategy Advisor and Business Analyst

    2016 - 2017